Systemic Therapy for Metastatic Renal-Cell Carcinoma
Dana-Farber Cancer Institute · Memorial Sloan Kettering Cancer Center
Indexed incrossrefpubmed
Abstract
Kidney cancers have been extensively studied, and insights from an increased understanding of tumor biology have led to increases in survival rates. Therapies aimed at tumor signaling pathways and immunotherapies have improved the outlook for patients with renal cancer.
Citation impact
1,318
total citations
- FWCI
- 96.61
- Percentile
- 100%
- References
- 90
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Medicine
- Renal cell carcinoma
- Kidney cancer
- Cancer
- Kidney
- Oncology
- Systemic therapy
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.